SEHK:1093
SEHK:1093Pharmaceuticals

Will New Depression and Metabolic Trial Approvals Change CSPC Pharmaceutical Group's (SEHK:1093) Narrative?

In late 2025, CSPC Pharmaceutical Group announced multiple regulatory approvals in the U.S. and China to begin clinical trials for innovative therapies targeting major depressive disorder, obesity and overweight with comorbidities, and complement-mediated diseases such as IgA nephropathy. By advancing a 5-HT2A agonist without hallucination risk, a dual-biased GLP-1/GIP agonist, and an ultra-long-acting C5 siRNA, CSPC is pivoting its pipeline toward high-demand areas where existing treatment...
SEHK:1428
SEHK:1428Capital Markets

Evaluating Bright Smart Securities & Commodities Group (SEHK:1428) After Its Profit-Improving Half-Year Results

Bright Smart Securities & Commodities Group (SEHK:1428) just posted its half year results, with revenue broadly flat but net income and earnings per share edging higher, hinting at better cost discipline behind the scenes. See our latest analysis for Bright Smart Securities & Commodities Group. The half year earnings tweak the narrative for Bright Smart Securities & Commodities Group, with a 1 year total shareholder return of 247.35 percent still looking strong. At the same time, the 90 day...
SEHK:2628
SEHK:2628Insurance

Is China Life’s New Subsidiary Agreements Quietly Redefining Its Risk Strategy (SEHK:2628)?

China Life Insurance Company Limited recently held its Second Extraordinary General Meeting, where shareholders considered resolutions on investment and management agreements with several subsidiaries that shape how capital and operations are coordinated across the group. This focus on group-wide investment and management frameworks highlights how China Life Insurance may be refining internal collaboration to support its evolving product mix and risk profile. We’ll now examine how this...
SEHK:596
SEHK:596Software

Reassessing Inspur Digital Enterprise Technology (SEHK:596)’s Valuation After Its Follow-On Equity Offering

Inspur Digital Enterprise Technology (SEHK:596) just wrapped up a follow on equity offering worth about HK$494 million, issuing over 67 million new ordinary shares at roughly HK$7.30 each. See our latest analysis for Inspur Digital Enterprise Technology. The follow on offering lands after a choppy stretch, with a roughly 9.7% 1 month share price return decline and a sharper 27.2% 3 month slide. This sits against a 5 year total shareholder return of over 300%, suggesting longer term momentum...
SEHK:2618
SEHK:2618Logistics

JD Logistics (SEHK:2618): A Fresh Look at Valuation After Recent Share Price Stabilisation

JD Logistics (SEHK:2618) has quietly inched higher this week, and that steady move is catching investors’ attention. With shares still down over the past year, the focus is shifting to whether fundamentals now justify a fresh look. See our latest analysis for JD Logistics. The modest climb in the 7 day share price return, against a still weak 1 year total shareholder return, suggests sentiment may be stabilising as investors reassess JD Logistics’ growth and margin prospects at around...
SEHK:6869
SEHK:6869Communications

Is Yangtze Optical Fibre And Cable (SEHK:6869) Using Governance Reforms To Redefine Its Long-Term Strategy?

At its extraordinary general meeting on December 5, 2025, Yangtze Optical Fibre and Cable Joint Stock Limited Company approved abolishing its supervisory board, amending its articles of association, and appointing Qiu Xiangping and Guan Jingzhi as non-executive directors. This overhaul of the company’s governance framework, including a reshaped board and committee structure, signals a meaningful shift in how oversight and leadership responsibilities are organized. We’ll examine how the...